Boston Scientific Announces U.S. and European Launch of Interlock-35 Fibered IDC Occlusion System


July 12, 2011
The Interlock-35 Fibered IDC Occlusion System for obstructing or reducing blood flow in the peripheral vasculature during embolization procedures. It consists of a 0.035-inch detachable coil that features a unique interlocking connection between the coil and delivery wire designed to offer excellent placement control, including the ability to advance, retract and reposition the coil before final deployment in the vessel.

The coil is engineered to be accurately and reliably detached by simply pushing the detachment zone beyond the distal end of the 5 French delivery catheter. The platinum coil is constructed with a dense network of synthetic fibers, designed to offer excellent thrombogenicity (blockage of blood flow) and rapid stasis.

Compatibility with 5 French catheters allows for placement of larger coils, which can help achieve peripheral embolization with fewer coils, potentially reducing procedure times.

The Interlock-35 Fibered IDC Occlusion System is available in 31 configurations that include coil lengths from 4 to 40 cm, diameters from 3 to 20 mm, and three distinct shapes (cube, 2-D helical and diamond) to offer physicians greater flexibility to treat diverse vessel anatomy. When combined with Boston Scientific's market-leading 0.018-inch Interlock Fibered IDC coils, the Interlock Coil portfolio provides 50 different coils to optimize peripheral embolization procedures.

The user-friendly interlocking arms provide control during coil deployment and detachment. The dense network of fibers provides rapid thrombosis, and the availability of larger and longer coils aid in effective vessel occlusion.

The coils were cleared for use in Europe and the United States in mid-2011.

For more information: